Using serum CA125 to assess the activity of potential cytostatic agents in ovarian cancer.
Hall MR, Petruckevitch A, Pascoe J, Persic M, Tahir S, Morgan JS, Gourley C, Stuart N, Crawford SM, Kornbrot DE, Qian W, Rustin GJ.
Hall MR, et al. Among authors: crawford sm.
Int J Gynecol Cancer. 2014 May;24(4):676-81. doi: 10.1097/IGC.0000000000000116.
Int J Gynecol Cancer. 2014.
PMID: 24651630